Literature DB >> 6283227

Effect of enzymatic disaggregation on proliferation of human tumor cells in soft agar.

A W Hamburger, C P White, K Tencer.   

Abstract

Cell suspensions were prepared by either mechanical or enzymatic disaggregation methods from biopsy specimens from 54 patients with various tumors. The biologic activities of cells derived from the two suspensions were then examined. Biopsy specimens of solid tumors were minced, and one-half of each specimen was further processed by being teased with needles, whereas the other half was exposed to a combination of collagenase, hyaluronidase, and DNase. The enzymatic disaggregation method yielded fewer cells per gram of tissue than the mechanical method. However, the percentage of dye-excluding cells was increased by the enzymatic procedure in 93% of the cases. Cells obtained by enzymatic means also had higher cloning efficiencies than those obtained by mincing. The histologic types of cells present in the initial cell suspensions were the same for cells obtained by the enzymatic or mechanical disaggregation methods. The number of colonies obtained was linearly related to the number of cells plated in both cases. The tritiated thymidine suicide indices (estimates of the percentage of cells in the S-phase of the cell cycle) were the same for the two cell populations obtained by the two methods. The results indicate that cells obtained from solid tumors by enzymatic dissociation methods did not differ significantly from cells obtained by the more conventional mechanical techniques. However, cell viabilities and cloning efficiencies were significantly improved by the enzymatic technique.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283227

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Stimulation of growth of human malignant lymphoma and lymphoid leukemia cells in vitro.

Authors:  E S Strobel; K J Bross; R Mertelsmann; F Herrmann
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

2.  A rapid method for the preparation of multiple samples of eucaryotic DNA.

Authors:  C D Reymond
Journal:  Nucleic Acids Res       Date:  1987-10-12       Impact factor: 16.971

3.  Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide).

Authors:  D S Alberts; J G Einspahr; R Struck; G Bignami; L Young; E A Surwit; S E Salmon
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

Review 4.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

5.  Cell kinetics and in vitro clonogenicity of primary colorectal cancer: clinicopathological relationships and the implications for chemotherapy.

Authors:  G A Trotter; G R Morgan; A J Cooper; N Kirkham; J M Whitehouse; I Taylor
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

6.  Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU.

Authors:  L C Panasci; M Dufour; L Chevalier; G Isabel; P Lazarus; A McQuillan; E Arbit; S Brem; W Feindel
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma.

Authors:  M E Berens; G Bjotvedt; D C Levesque; M D Rief; J R Shapiro; S W Coons
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

8.  In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.

Authors:  P Lazarus; M Dufour; G Isabel; L C Panasci
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells.

Authors:  Jon G Quatromoni; Sunil Singhal; Pratik Bhojnagarwala; Wayne W Hancock; Steven M Albelda; Evgeniy Eruslanov
Journal:  J Leukoc Biol       Date:  2014-10-30       Impact factor: 4.962

10.  Secretion of transforming growth factors by primary human tumour cells.

Authors:  A W Hamburger; C P White; F E Dunn
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.